Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0001562180-19-003915

Chief Executive Officer sold 33,031 shares at an average $212.60 ($7,022,524)

  • Chief Executive Officer acquired 33,031 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kummeth Charles R. Chief Executive Officer 2019-07-08 Option exercise +17,994 $67.46 $1,213,875 110,170 D: show line 1 in the form
Kummeth Charles R. Chief Executive Officer 2019-07-08 Sale −17,994 $212.75 $3,828,184 92,176 D: show line 2 in the form
Kummeth Charles R. Chief Executive Officer 2019-07-09 Option exercise +15,037 $67.46 $1,014,396 107,213 D: show line 3 in the form
Kummeth Charles R. Chief Executive Officer 2019-07-09 Sale −15,037 $212.43 $3,194,340 92,176 D: show line 4 in the form
Open-market sales · 33,031 sh · avg $212.60 · $7,022,524

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Kummeth Charles R. Chief Executive Officer 2019-07-08 Option exercise · Stock Options (Right to buy) −17,994 32,006 D: show line 5 in the form
Kummeth Charles R. Chief Executive Officer 2019-07-09 Option exercise · Stock Options (Right to buy) −15,037 16,969 D: show line 6 in the form
Loading xslF345X03/primarydocument.xml…